Secreted Group IIA Phospholipase A2 Protects Humans Against the Group B Streptococcus: Experimental and Clinical Evidence
Open Access
- 30 July 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 208 (12) , 2025-2035
Abstract
Group B streptococcus (GBS) is a leading neonatal pathogen and a growing cause of invasive disease in the elderly, with clinical manifestations such as pneumonia and sepsis. Despite its clinical importance, little is known about innate immunity against GBS in humans. Here, we analyze the role of human group IIA secreted phospholipase A2 (sPLA2-IIA), a bactericidal enzyme induced during acute inflammation, in innate immunity against GBS. We show that clinical GBS isolates are highly sensitive to killing by sPLA2-IIA but not by human antimicrobial peptides. Using transgenic mice that express human sPLA2-IIA, we demonstrate that this enzyme is crucial for host protection against systemic infection and lung challenge by GBS. We found that acute sera from humans diagnosed with invasive GBS disease contain increased levels of sPLA2-IIA compared with normal sera from healthy individuals, indicating that GBS induces an sPLA2-IIA response in blood during human infection. We demonstrate that clinically relevant GBS strains are rapidly killed in these acute sera. We also demonstrate that the bactericidal effect is entirely due to sPLA2-IIA, showing that sPLA2-IIA might represent an important component of humoral innate immunity against GBS. Our data provide experimental and clinical evidence that sPLA2-IIA protects humans against GBS infections.Keywords
This publication has 47 references indexed in Scilit:
- A Novel Bacterial Resistance Mechanism against Human Group IIA-Secreted Phospholipase A2: Role of Streptococcus pyogenes Sortase AThe Journal of Immunology, 2011
- Secretory phospholipase A2: a marker of infection in febrile children presenting to a pediatric EDThe American Journal of Emergency Medicine, 2011
- Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the hostBiochimie, 2010
- Expression of phospholipases A2 in primary human lung macrophagesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Antibacterial actions of secreted phospholipases A2. ReviewBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Edema Toxin Impairs Anthracidal Phospholipase A2 Expression by Alveolar MacrophagesPLOS Pathogens, 2007
- Neisseria meningitidispili induce type-IIA phospholipase A2expression in alveolar macrophagesFEBS Letters, 2005
- Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serumBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- Antimicrobial peptides of multicellular organismsNature, 2002
- Bactericidal properties of murine intestinal phospholipase A2.Journal of Clinical Investigation, 1995